IBDEI1A0 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22607,0)
 ;;=581.9^^125^1395^37
 ;;^UTILITY(U,$J,358.3,22607,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22607,1,4,0)
 ;;=4^581.9
 ;;^UTILITY(U,$J,358.3,22607,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,22607,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,22608,0)
 ;;=753.12^^125^1395^43
 ;;^UTILITY(U,$J,358.3,22608,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22608,1,4,0)
 ;;=4^753.12
 ;;^UTILITY(U,$J,358.3,22608,1,5,0)
 ;;=5^Polycystic Kidney Disease
 ;;^UTILITY(U,$J,358.3,22608,2)
 ;;=^67295
 ;;^UTILITY(U,$J,358.3,22609,0)
 ;;=791.0^^125^1395^45
 ;;^UTILITY(U,$J,358.3,22609,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22609,1,4,0)
 ;;=4^791.0
 ;;^UTILITY(U,$J,358.3,22609,1,5,0)
 ;;=5^Proteinuria
 ;;^UTILITY(U,$J,358.3,22609,2)
 ;;=Proteinuria^99873
 ;;^UTILITY(U,$J,358.3,22610,0)
 ;;=791.9^^125^1395^48
 ;;^UTILITY(U,$J,358.3,22610,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22610,1,4,0)
 ;;=4^791.9
 ;;^UTILITY(U,$J,358.3,22610,1,5,0)
 ;;=5^Pyuria
 ;;^UTILITY(U,$J,358.3,22610,2)
 ;;=^273408
 ;;^UTILITY(U,$J,358.3,22611,0)
 ;;=592.0^^125^1395^49
 ;;^UTILITY(U,$J,358.3,22611,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22611,1,4,0)
 ;;=4^592.0
 ;;^UTILITY(U,$J,358.3,22611,1,5,0)
 ;;=5^Renal Calculi
 ;;^UTILITY(U,$J,358.3,22611,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,22612,0)
 ;;=403.91^^125^1395^50
 ;;^UTILITY(U,$J,358.3,22612,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22612,1,4,0)
 ;;=4^403.91
 ;;^UTILITY(U,$J,358.3,22612,1,5,0)
 ;;=5^Renal Failure, Chronic Hypertensive
 ;;^UTILITY(U,$J,358.3,22612,2)
 ;;=^269610
 ;;^UTILITY(U,$J,358.3,22613,0)
 ;;=586.^^125^1395^53
 ;;^UTILITY(U,$J,358.3,22613,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22613,1,4,0)
 ;;=4^586.
 ;;^UTILITY(U,$J,358.3,22613,1,5,0)
 ;;=5^Uremia
 ;;^UTILITY(U,$J,358.3,22613,2)
 ;;=Uremia^104733
 ;;^UTILITY(U,$J,358.3,22614,0)
 ;;=599.0^^125^1395^65
 ;;^UTILITY(U,$J,358.3,22614,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22614,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,22614,1,5,0)
 ;;=5^Urinary Tract Infection
 ;;^UTILITY(U,$J,358.3,22614,2)
 ;;=Urinary Tract Infection^124436
 ;;^UTILITY(U,$J,358.3,22615,0)
 ;;=275.42^^125^1395^28
 ;;^UTILITY(U,$J,358.3,22615,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22615,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,22615,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,22615,2)
 ;;=Hypercalcemia^59932
 ;;^UTILITY(U,$J,358.3,22616,0)
 ;;=275.41^^125^1395^31
 ;;^UTILITY(U,$J,358.3,22616,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22616,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,22616,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,22616,2)
 ;;=Hypocalcemia^60542
 ;;^UTILITY(U,$J,358.3,22617,0)
 ;;=276.7^^125^1395^29
 ;;^UTILITY(U,$J,358.3,22617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22617,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,22617,1,5,0)
 ;;=5^Hyperkalemia/Hyperpotassemia
 ;;^UTILITY(U,$J,358.3,22617,2)
 ;;=Hyperkalemia/Hyperpotassemia^60042
 ;;^UTILITY(U,$J,358.3,22618,0)
 ;;=276.8^^125^1395^32
 ;;^UTILITY(U,$J,358.3,22618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22618,1,4,0)
 ;;=4^276.8
 ;;^UTILITY(U,$J,358.3,22618,1,5,0)
 ;;=5^Hypokalemia/Hypopotassemia
 ;;^UTILITY(U,$J,358.3,22618,2)
 ;;=Hypokalemia/Hypopotassemia^60611
 ;;^UTILITY(U,$J,358.3,22619,0)
 ;;=275.2^^125^1395^26
 ;;^UTILITY(U,$J,358.3,22619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22619,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,22619,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,22619,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,22620,0)
 ;;=276.0^^125^1395^30
 ;;^UTILITY(U,$J,358.3,22620,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1A0
